Leidos Health Life Sciences Receives Patent for Novel Peptide-Class of Checkpoint Inhibitors GuruFocus.com
Leidos Health Life Sciences Receives Patent for Novel Peptide-Class of Checkpoint Inhibitors, Stocks: NYSE:LDOS, release date:Jan 03, 2019.
Leidos Health Life Sciences Receives Patent for Novel Peptide-Class of Checkpoint Inhibitors GuruFocus.com
Leidos Health Life Sciences Receives Patent for Novel Peptide-Class of Checkpoint Inhibitors, Stocks: NYSE:LDOS, release date:Jan 03, 2019.